Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene Gel for Acute Radiation Dermatitis
NCT07886320Phase 1Recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Mar 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of adapalene in radiation dermatitis (2 arms), sponsored by Yunnan Cancer Hospital. Primary endpoint: RTOG/EORTC Acute Radiation Morbidity Score for Skin Reactions in the Irradiated Field up to 6 weeks. Started Mar 2026; status: recruiting.
02
Drugs
adapalene
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT07886320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07886320.